TY - JOUR
T1 - NRT about doubles the quit rates of behavioral interventions alone Nicotine replacement therapy
T2 - What are the options today?
AU - Rennard, Stephen I.
PY - 1998
Y1 - 1998
N2 - Four formulations of nicotine replacement therapy (NRT) have been approved by the PDA-the patch, gum, a nasal spray, and an inhaler. The goal when administering NRT is to prevent the onset of withdrawal symptoms and reduce nicotine cravings. The ideal dosage of NRT provides nicotine below the level absorbed while smoking, thereby discouraging the addiction that had been caused by smoking. NRT significantly improves smoking quit rates and therefore merits consideration in all patients attempting to quit, including most of those with coronary artery disease. The nicotine patch provides a steady serum level of nicotine. The other formulations can be given along with the patch for use when the craving is strong or withdrawal symptoms are troublesome.
AB - Four formulations of nicotine replacement therapy (NRT) have been approved by the PDA-the patch, gum, a nasal spray, and an inhaler. The goal when administering NRT is to prevent the onset of withdrawal symptoms and reduce nicotine cravings. The ideal dosage of NRT provides nicotine below the level absorbed while smoking, thereby discouraging the addiction that had been caused by smoking. NRT significantly improves smoking quit rates and therefore merits consideration in all patients attempting to quit, including most of those with coronary artery disease. The nicotine patch provides a steady serum level of nicotine. The other formulations can be given along with the patch for use when the craving is strong or withdrawal symptoms are troublesome.
UR - http://www.scopus.com/inward/record.url?scp=0343152434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0343152434&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0343152434
SN - 0194-259X
VL - 19
SP - S20-S25
JO - Journal of Respiratory Diseases
JF - Journal of Respiratory Diseases
IS - 8 SUPPL.
ER -